ArticleACS materials Au2026
Cytotoxicity Assessment and Indentation Size Effect of Low-Cost Experimental Implant Alloys.
Article in ACS materials Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of affordable lightweight alloys with a combination of high mechanical strength and excellent biocompatibility is crucial for next-generation biomedical implants, particularly for middle- and low-income classes. This study investigates the relationship between processing, microscale mechanical behavior, and cytotoxicity of experimental titanium alloys (Ti-3Fe, Ti-4.5Al-1 V-3Fe, and Ti-6Al-1 V-3Fe) and a low-density stainless-steel (LDSS) alloy (Fe-20Mn-7Al-1C-3Cr-3Cu-3Mo), produced via casting and sintering. Their performance was benchmarked against those of commercial Ti-6Al-4 V and 316L stainless steel. Micro- and macro-indentation tests were conducted to evaluate the indentation size effect (ISE), and the Nix-Gao model was applied to quantify strain-gradient plasticity through the estimation of statistically stored dislocation (SSD) and geometrically necessary dislocation (GND) densities. In parallel, in vitro cytotoxicity was evaluated using NIH-3T3 fibroblast cells following the ISO 10993-5 guidelines. The experimental titanium alloys exhibited pronounced ISE behavior and the highest GND densities, indicating enhanced resistance to plastic deformation at the microscale compared to the LDSS alloys. Cytotoxicity results showed excellent biocompatibility for Ti-6Al-4 V and 316L and good compatibility for the experimental Ti-Fe alloys, with cell viability exceeding 70% at 100% extract concentration. In contrast, the LDSS alloys showed the lowest cell viability, with both the as-cast and sintered LDSS having a cell viability of less than 70%, thereby necessitating a detailed corrosion performance evaluation and further optimization. This performance was correlated with high Mn dissolution detected in the extract medium after the cytotoxicity assessment. The results demonstrate that experimental titanium alloys provide a promising pathway toward lightweight biomedical implant materials that combine microscale strengthening with acceptable biocompatibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.